title: Reply to G. Gandaglia et al.
authors.affiliation: University of Rochester Medical Center, James P. Wilmot Cancer Center, Rochester, NY.
authors.forename: Chunkit
authors.initials: C
authors.lastname: Fung
authors.forename: Sophie D
authors.initials: SD
authors.lastname: Fossa
authors.forename: Michael T
authors.initials: MT
authors.lastname: Milano
authors.forename: Jan
authors.initials: J
authors.lastname: Oldenburg
authors.forename: Lois B
authors.initials: LB
authors.lastname: Travis
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy* / Q000601:surgery*; D016609:Neoplasms, Second Primary / Q000453:epidemiology*; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000601:surgery*